Celldex Therapeutics | CLDX - DEBITO

Prezzo Delle Azioni
29.26
Cambio Giornaliero
0.72 2.52%
Mensile
27.11%
Annuale
47.18%
Q1 Previsione
28.62




DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Celldex Therapeutics USD 2.62M 410K 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 60.85B 78M 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06